Alain Jean Jacot

Corporate Officer/Principal at Galderma Holding SA

73 year

Health Technology

Profile

Alain Jean Jacot is currently the Vice President-Scientific Division at Galderma Holding SA since 2015.
Prior to this, he worked as a Director at Q-Med AB.

Alain Jean Jacot active positions

Companies	Position	Start
Galderma Holding SA Galderma Holding SA Pharmaceuticals: MajorHealth Technology Galderma Holding SA owns shares and interest of manufacturers and distributors of dermatological and skin care products. The company is headquartered in La Tour-de-Peilz, Swtzerland.	Corporate Officer/Principal	2015-03-11

All active positions of Alain Jean Jacot

Former positions of Alain Jean Jacot

Companies	Position	End
Q-Med AB Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden.	Director/Board Member	-

See the detail of Alain Jean Jacot's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Alain Jean Jacot's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Galderma Holding SA Galderma Holding SA Pharmaceuticals: MajorHealth Technology Galderma Holding SA owns shares and interest of manufacturers and distributors of dermatological and skin care products. The company is headquartered in La Tour-de-Peilz, Swtzerland.	Health Technology
Q-Med AB Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden.	Health Technology